Subscribe To
Avalon globocare shares surge as recent momentum continues
Avalon GloboCare Corp (NASDAQ:ALBT) shares climbed 29% to $1.24 on Tuesday after the precision diagnostics and clinical laboratory services provider ...
September 5, 2023, 2:43 pm
Merck and eisai cull late-stage study for head and neck cancer therapy
Merck & Co Inc (NYSE:MRK) and research partner Eisai said they are halting a late-stage trial that used a combination of drugs to treat a type of head...
August 25, 2023, 7:58 am
Centessa pharmaceuticals to present preclinical data for novel orexin receptor 2 (ox2r) agonist at world sleep congress
Oral presentation to include preclinical profile for ORX750, Centessa's first orexin agonist development candidate for the treatment of narcolepsy and...
August 23, 2023, 5:08 pm
Atossa therapeutics is targeting multiple stages of the breast cancer continuum with oral endoxifen
Atossa Therapeutics Inc (NASDAQ:ATOS) is targeting three different stages of the breast cancer continuum with its proprietary oral form of Endoxifen, ...
August 23, 2023, 1:16 pm
Abbvie (abbv) gets eu approval for migraine prevention drug
Following the approval, AbbVie's (ABBV) Aquipta is the first and the only oral CGRP receptor antagonist...
August 17, 2023, 1:17 pm
Akero therapeutics reports second quarter 2023 financial results and provides business update
— Positive Results from Phase 2b SYMMETRY Cohort D, an expansion cohort of Type 2 diabetic, pre-cirrhotic NASH patients treated with EFX or placebo ...
August 11, 2023, 10:00 am
Altimmune announces initiation of phase 2b impact trial evaluating the efficacy and safety of pemvidutide in non-alcoholic steatohepatitis (nash)
GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that ...
August 1, 2023, 11:30 am
Amgen: huge potential with biosimilars and glp-1
Amgen is now down nearly 20% since last November as money continues to rotate from defensive sectors into tech. The biopharma company should benefit f...
July 24, 2023, 12:38 pm
Artelo biosciences to present new mechanism of action data on art26.12 at the gordon research conference on july 20, 2023
New data demonstrates that ART26.12 works by activating multiple receptors implicated in pain signaling...
July 19, 2023, 9:00 am
Rhythm pharmaceuticals to report second quarter 2023 financial results on tuesday, august 1, 2023
BOSTON, July 18, 2023 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transf...
July 15, 2023, 6:29 am
Rhythm pharmaceuticals to report second quarter 2023 financial results on tuesday, august 1, 2023
BOSTON, July 18, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transf...
July 15, 2023, 2:12 am
Atossa therapeutics strikes sponsored research deal with weill cornell medicine for triple negative breast cancer
Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, announced a sponsored research agreement wit...
July 6, 2023, 12:26 pm
Rite aid rides ozempic wave but fails to profit
During its fiscal first quarter, Rite Aid reported a boost in pharmacy sales, attributed to the introduction of a new category of drugs. Pharmacy sa...
June 29, 2023, 5:36 pm
Atossa therapeutics hits 30% enrollment for (z)-endoxifen arm of ongoing i-spy 2 clinical trial
Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, revealed that six patients have been dosed w...
June 28, 2023, 11:01 am
Black diamond therapeutics stock rockets after positive trial data shows anti-tumor activity
Black Diamond Therapeutics Inc shares doubled after it saw positive initial dose escalation data from a study demonstrating the anti-tumor activity of...
June 27, 2023, 11:56 am
Instil bio announces oral presentation of itil-306 preclinical data at british society for gene and cell therapy annual conference
Presented data showing that folate receptor α (FRα)-CoStAR enhanced activity of TILs against autologo...
June 26, 2023, 8:38 pm
Biora therapeutics presents data on the biojet™ systemic oral delivery platform at the american diabetes association 83rd scientific sessions
An average bioavailability of 37% for a GLP-1 receptor agonist was achieved in animals SAN DIEGO, June ...
June 26, 2023, 10:00 am
Replay and md anderson announce fda clearance of ind application for first-in-class t-cell receptor natural killer (tcr-nk) cell therapy for sarcoma
Replay and MD Anderson announce FDA clearance of IND application for first-in-class T–Cell receptor N...
June 20, 2023, 11:00 am
Why shares of adaptive biotechnologies jumped this week
Adaptive is awaiting an approval from the FDA on solid-tumor therapy afami-cel. The company uses a T-cell rece...
June 16, 2023, 5:02 pm
New publication highlights basic science supporting simufilam
Publication Reviews Certain receptor-Protein Interactions. Provides Overview of Basic Science Supportin...
June 12, 2023, 1:15 pm